UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
EU approvals for Samsung Bioepis push up share prices
by Nam Doo-hyun
2017-09-18 14:45
‘Knowledge’ is core ability for bio industrialists, survey says
by Nam Doo-hyun
2017-09-15 16:28
Experts call for overhauling bio industry promotion policy
by Nam Doo-hyun
2017-09-15 15:39
New VC investments in bio, medical fields fall sharpest in H1
by Nam Doo-hyun
2017-09-13 13:23
China, Australia emerge as promising markets for medical equipment makers
by Nam Doo-hyun
2017-09-12 17:40
라인
Brokerage analyzes profit-sharing structure of Celltrion group
by Nam Doo-hyun
2017-09-12 16:55
Drugmakers adopt VR in sales, promotion
by Nam Doo-hyun
2017-09-11 17:21
Experts stress need for drug treatments to control cholesterol
by Nam Doo-hyun
2017-09-11 12:01
Investment into GMP facility needed to export bio medicines
by Nam Doo-hyun
2017-09-11 11:59
Drugmakers introduce VR for diabetes therapy
by Nam Doo-hyun
2017-09-06 17:12
라인
Papers related to stem cell therapy rising worldwide
by Nam Doo-hyun
2017-09-06 16:45
‘Mooncare’ helps bio, pharmaceutical stocks overcome NK risks
by Nam Doo-hyun
2017-09-05 16:45
Survey tracks reasons Chinese come to Korea for cosmetic surgery
by Nam Doo-hyun
2017-09-04 14:20
‘AI to boost success rates, effectiveness for clinical trials’
by Nam Doo-hyun
2017-08-28 14:34
Ferring’s offshoot swindled by email mimicking headquarter office
by Nam Doo-hyun
2017-08-25 17:54
라인
Pharmaceutical sectors of major countries show mixed results
by Nam Doo-hyun
2017-08-24 18:35
Quadrivalent influenza vaccines enter fierce sales competition
by Nam Doo-hyun
2017-08-24 15:04
Bio firms blame small R&D spending for low technology
by Nam Doo-hyun
2017-08-24 11:31
Triumeq aims to change HIV drug market with easy use
by Nam Doo-hyun
2017-08-23 12:12
Celltrion’s move to main stock market draws investor concern
by Nam Doo-hyun
2017-08-22 17:01
-
이전
11
12
13
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top